Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEPress Release▲ PositiveResults30 Jul 2026

JBM Auto Limited

Press Release

JBM Auto Limited has announced its unaudited financial results for the first quarter of FY27, reporting a 15.04% increase in revenues and a 15.96% increase in net profit compared to the same period last year. The company's EV business registered a 16.67% increase in revenues and retained its market leadership with a ~25% market share in Q1FY27.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults30 Jul 2026

Niva Bupa Health Insurance Company Limited

Press Release

Niva Bupa Health Insurance Company Limited reported a Profit After Tax (PAT) of ₹138 crore, registering a robust 93% year-on-year growth. The company sustained its healthy growth momentum in the first quarter, reporting Gross Written Premium (GWP) of ₹2,150 crore, up 32%. Niva Bupa's retail health business registered a robust 47% growth, contributing to an increase in Retail Health Market Share to 11.1%.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults30 Jul 2026

Lodha Developers Ltd

Transcript of Earning Conference Call held on July 27, 2026

Lodha Developers Ltd's Q1FY27 earnings conference call transcript was released, with management highlighting 20% PAT growth guidance, strong residential engine, and land monetization plans. Revenue was INR 50 billion, up 43% YoY, with adjusted EBITDA at INR 21.5 billion and PAT at INR 13.7 billion. Net debt was reduced by INR 4.5 billion to under INR 50 billion.

Read more →📎 1 attachment
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults30 Jul 2026

Lodha Developers Limited

Analysts/Institutional Investor Meet/Con. Call Updates

Lodha Developers Limited has informed the Exchange about Transcript on Unaudited Financial Results for the quarter ended June 30, 2026. The company's Q1 FY27 Earnings Conference Call transcript is available on the company's website. The highlights of the performance for this quarter include revenue of INR 50 billion, up 43% year-on-year, adjusted EBITDA of INR 21.5 billion, up 79% at a margin of 43%, and PAT of INR 13.7 billion, more than double the INR 6.8 billion of Q1 FY26.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults30 Jul 2026

Jasch Gauging Technologies Ltd

Unaudited standalone financial results for the quarter ended on 30.06.2026 along with limited review report of the auditors and Interim Dividend were approved.

Jasch Gauging Technologies Ltd has announced unaudited standalone financial results for the quarter ended 30.06.2026, with revenue from operations at Rs. 1,468.24 lakh and profit from continuing operations at Rs. 368.51 lakh. The company has also declared an interim dividend of Rs. 10 per equity share.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults30 Jul 2026

Fairchem Organics Ltd

Please find attached herewith transcript of Earning''s Con-Call held on Tuesday, July 28, 2026 for the Unaudited Financial Results for the Quarter Ended June 30, 2026

Fairchem Organics Ltd. has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 176 crores, a 34.4% year-on-year increase. EBITDA for the quarter was Rs. 18 crores with an EBITDA margin of 10.14%. The net profit for the quarter was Rs. 10 crores.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveResults30 Jul 2026

Paushak Ltd

Outcome of Board Meeting

Paushak Ltd announced its unaudited financial results for the quarter ended 30th June, 2026, with a profit before tax of Rs 1,902 lakhs, a tax expense of Rs 391 lakhs, and a profit after tax of Rs 1,510 lakhs. The company's earnings per share (EPS) for the quarter was Rs 6.13.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults30 Jul 2026

Niva Bupa Health Insurance Company Ltd

Investor Presentation of the Earnings call scheduled today i.e. on July 30, 2026

Niva Bupa Health Insurance Company Ltd has announced its Q1FY2027 results, with a 31.7% y-o-y growth in Gross Written Premium (GWP) to ₹ 2,150 crore and a near doubling of Profit After Tax (PAT) to ₹ 137.8 crore. The company has also transitioned to Indian Accounting Standards (Ind AS) from Q1FY2027, which is expected to enhance financial transparency and align reporting practices with global benchmarks.

Read more →📎 1 attachment
BSEResult▲ PositiveResults30 Jul 2026

Jasch Gauging Technologies Ltd

Unaudited Standalone Financial Results for the quarter ended on 30.06.2026 along with limited review report of auditors.

Jasch Gauging Technologies Ltd has announced unaudited standalone financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 1,468.24 lakhs and profit from continuing operations at Rs. 368.51 lakhs. The company has also declared an interim dividend of Rs. 10 per equity share.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults30 Jul 2026

Transport Corporation of India Limited

Press Release

Transport Corporation of India Ltd. (TCI) announced its financial results for the first quarter ended June 30, 2026, with a consolidated revenue of ₹12548 Mn, a 9.1% increase from ₹11506 Mn in the same period last year. EBITDA stood at ₹1599 Mn, a 5.2% increase from ₹1520 Mn in Q1/FY2026. Profit after Tax (PAT) decreased by 0.6% to ₹1066 Mn, compared to ₹1072 Mn in the corresponding quarter of the previous year.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults30 Jul 2026

Swiggy Ltd

Press Release for the Unaudited Financial Results (consolidated & standalone) for the quarter ended June 30, 2026

Swiggy Ltd reported unaudited financial results for Q1FY27, with overall revenue growing 34.0% YoY to INR 7,112 Cr, and Food Delivery business Gross Order Value (GOV) growing 17.4% YoY to INR 9,490 Cr. Adjusted EBITDA improved by INR 100 Cr YoY to INR 292 Cr, and Quick Commerce hit Contribution break-even in May'26.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults30 Jul 2026

Mankind Pharma Ltd

Please find attached press release on financial results of the Company for Q1FY27

Mankind Pharma Ltd reported Q1FY27 financial results with revenue growth of 12.9% YoY, EBITDA growth of 24.7% YoY, and PAT growth of 29.1% YoY. The company's domestic business (ex-CH) grew by 11.0% led by double-digit growth in Mankind domestic business, while OTC segment grew by ~4% and International business grew 29% YoY.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults30 Jul 2026

Swiggy Ltd

Shareholders'' Letter for Q1 FY 2026-27 dated July 30, 2026

Swiggy Ltd has announced its Q1 FY 2026-27 Shareholders' Letter, highlighting the company's achievement of contribution margin break-even in quick commerce. The letter also discusses the company's growth, user base, economics, and experience, as well as its plans to expand its network and launch new initiatives.

Read more →📎 1 attachment
NSEPress Release▲ PositiveResults30 Jul 2026

Mankind Pharma Limited

Press Release

Mankind Pharma Limited has announced its Q1FY27 financial results, showing revenue growth of 12.9% YoY, EBITDA growth of 24.7% YoY, and PAT growth of 29.1% YoY. The company's domestic business (ex-CH) grew by 11.0% YoY, driven by double-digit growth in Mankind business and strong growth in BSV specialty business. The company has also launched 1 new product in Q1FY27, taking the total launched products to 49 in the US.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults30 Jul 2026

Mankind Pharma Ltd

Please find attached investor presentation for Q1FY27

Mankind Pharma Ltd has announced its Q1FY27 investor presentation, showcasing a 12.9% YoY growth in revenue from operations, with domestic business (ex-CH) growing 10.5% YoY and exports business growing 29% YoY. The company has also reported a 16.5% YoY growth in gross profit and a 24.7% YoY growth in EBITDA. The presentation highlights the company's steady growth trajectory, expansion in specialty and super specialty segments, and strong performance in key focused brands.

Read more →📎 1 attachment
NSEInvestor Presentation▲ PositiveResults30 Jul 2026

Mankind Pharma Limited

Investor Presentation

Mankind Pharma Limited has announced its Q1 FY27 financial results, showing a 12.9% YoY growth in revenue from operations, with domestic business (ex-CH) growing 11.0% YoY and exports business growing 29.0% YoY. The company has also reported a 16.5% YoY growth in gross profit and a 24.7% YoY growth in EBITDA.

Read more →📎 1 attachment
NSEGeneral Updates▲ PositiveResults30 Jul 2026

Colgate Palmolive (India) Limited

General Updates

Colgate-Palmolive (India) Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a net sales growth of 12% and a net profit growth of 11% excluding one-offs and exceptional items. The company has also won several awards for its innovative campaigns and sustainability initiatives.

Read more →📎 1 attachment
← PreviousPage 812 of 998Next →